AbbVie Reports Second-Quarter 2019 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/18/2026
- Tech selloff weighs down Wall Street as bond yields climb
- Baidu slips as Q2 results miss estimates despite growth in AI cloud business
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
- Home Depot beats estimates, reaffirms fiscal 2026 guidance
- Citi says positioning risk is shifting from short squeezes to profit-taking
- Wall Street indexes slip as oil prices rise, retail results awaited
- Tech selloff weighs down Wall Street as bond yields climb
- Micron rises as White House presses Apple to avoid Chinese memory chips
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Francisco Partners to acquire Weave Communications for $650M
AbbVie (ABBV) Tops Q2 EPS by 6c, Revenue Beats, Updates FY Guidance
July 26, 2019 7:44 AM EDTAbbVie (NYSE: ABBV) reported Q2 EPS of $2.26, $0.06 better than the analyst estimate of $2.20. Revenue for the quarter came in at $8.26 billion versus the consensus estimate of $8.1 billion.
GUIDANCE:
AbbVie sees FY2019 EPS of $8.82-$8.92, versus the consensus of... More
